Literature DB >> 1489200

Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.

A Fernandez-Rodriguez1, R Canton, J C Perez-Diaz, J Martinez-Beltran, J J Picazo, F Baquero.   

Abstract

The aminoglycoside-modifying enzymes present in the first 120 clinical isolates harboring extended-spectrum beta-lactamases isolated in Spain were studied. Most of these isolates (84%) were gentamicin resistant. The enzymes most frequently associated and cotransferred with SHV-2 or TEM-type beta-lactamases were AAC(3)V, APH(3"), and APH(3')I.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1489200      PMCID： PMC284369          DOI： 10.1128/AAC.36.11.2536

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Resistance to aminoglycoside antibiotics in gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. The ESGAR Study Group (European Study Group on Antibiotic Resistance).

Authors:  K Dornbusch; G H Miller; R S Hare; K J Shaw
Journal:  J Antimicrob Chemother       Date:  1990-07       Impact factor: 5.790

2.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Epidemiology of extended spectrum beta-lactamases.

Authors:  A Philippon; S Ben Redjeb; G Fournier; A Ben Hassen
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

4.  Aminoglycoside-modifying enzymes.

Authors:  M J Haas; J E Dowding
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

Review 5.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

6.  Purification and properties of an aminoglycoside acetyltransferase from Pseudomonas aeruginosa.

Authors:  R G Coombe; A M George
Journal:  Biochemistry       Date:  1982-03-02       Impact factor: 3.162

7.  Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase.

Authors:  A Petit; G Gerbaud; D Sirot; P Courvalin; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

8.  Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae.

Authors:  M H Nicolas; V Jarlier; N Honore; A Philippon; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

9.  TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.

Authors:  G C Paul; G Gerbaud; A Bure; A M Philippon; B Pangon; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Bleomycin-kanamycin resistance as a marker of the presence of transposon Tn5 in clinical strains of Escherichia coli.

Authors:  F Baquero; M A Saldaña; J Blazquez; R G Palacios; J M Aguiar; J L Martinez; M F Vicente; C Rubio; R Gómez-Lus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-11       Impact factor: 3.267
View more
  4 in total

1.  New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak.

Authors:  M I Morosini; R Canton; J Martinez-Beltran; M C Negri; J C Perez-Diaz; F Baquero; J Blazquez
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

2.  Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000).

Authors:  Teresa M Coque; Antonio Oliver; José Claudio Pérez-Díaz; Fernando Baquero; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 3.  Origin and impact of plasmid-mediated extended-spectrum beta-lactamases.

Authors:  A Philippon; G Arlet; P H Lagrange
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

4.  Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase- and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species.

Authors:  Ghady Haidar; Ammar Alkroud; Shaoji Cheng; Travis M Churilla; Bryce M Churilla; Ryan K Shields; Yohei Doi; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.